Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310037
Status:
UNKNOWN
Last Update Posted:
2021-08-18
First Post:
2006-03-29
Brief Title:
Bortezomib After Combination Chemotherapy Rituximab and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Organization Data
Organization:
Alliance for Clinical Trials in Oncology
Class:
OTHER
Study ID:
CALGB-50403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Millennium Pharmaceuticals Inc | INDUSTRY |